Alembic Pharmaceuticals gets ANDA approval for Telmisartan and Amlodipine Tablets

From USFDA

Alembic Pharmaceuticals has received approval for its abbreviated new drug application (ANDA) for Telmisartan and Amlodipine Tablets, 40mg/5mg, 40mg/10mg, 80mg/5mg and 80mg/10mg from the United States Food and Drug Administration. The tablets are indicated for the treatment of hypertension, alone or with antihypertensive agents to reduce blood pressure.

Powered by Capital Market - Live News